Clinical Trials Browser

Phase 1/2 × Neoplasms × Melphalan × Clear all

NCT00793650 2012-08-30

Combination High Dose Melphalan and Autologous Peripheral Blood Stem Cell (PBSC) Transplant With Bortezomib for Multiple Myeloma: A Dose and Schedule Finding Study

Phase 1/2 Terminated

39 enrolled 9 charts

Multiple Myeloma, Neoplasms

NCT00421811 2010-12-28

A Study of ADH-1 in Combination With Normothermic Isolated Limb Infusion of Melphalan

Phase 1/2 Completed

Melanoma, Neoplasms